Feds Spent Even More on PrEP Combo Than Previously Thought
New estimate says taxpayers spent over $140 million to study Truvada as HIV prevention
Source: medpagetoday.com
Page 7 - Program On Regulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Program On Regulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Program On Regulation Today - Breaking & Trending Today
Supreme Court Preserves Access to Abortion Pill Pending Appeal
The nation’s highest court paused a lower court’s decision to nullify approval of the abortion drug mifepristone, keeping the medication available while an appeal moves forward
Source: scientificamerican.com
Comment: Abortion pill ruling threat to approval of new drugs
A Texas judge’s rejection of an FDA-approved drug could chill development and use of other medications.
Source: heraldnet.com
Lisa Jarvis: Abortion pill ruling threatens pharmaceutical innovation
A Texas federal judge’s ruling to remove the 23-year-old drug mifepristone from the market not only threatens abortion access in the U.S. — it’s also an appalling sideswipe at the
Source: henryherald.com
Follow-Up Trials for Accelerated Approval Drugs Often Miss FDA Deadline
Data suggest confirmatory trials conducted for drugs granted accelerated approval by the FDA have taken a median 3.5 years to complete since 2012.
Source: hcplive.com